Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
European Review for Medical and Pharmacological Sciences|May 26, 2010
Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analoguesL Bodei, G Pepe, G Paganelli
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 18, 2006
Systemic and locoregional dosimetry in receptor radionuclide therapy with peptidesM Cremonesi, M Ferrari, L Bodei, et al.
La Radiologia Medica|July 22, 1999
[Study and implementation of a computerized program for personalized prescriptions for patients treated with radioiodine to be discharged]S Puccini, A C Traino, M Ferdeghini, et al.
The American Journal of Gastroenterology|June 3, 2015
The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tractI M Modlin, M Kidd, L Bodei, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 10, 2011
Dosimetry in nuclear medicine therapy: radiobiology application and resultsL Strigari, M Benassi, C Chiesa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotideS Ricci, A Antonuzzo, L Galli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 3, 2007
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"B Brans, L Bodei, F Giammarile, et al.
Journal of Endocrinological Investigation|July 29, 2009
Peptide receptor therapies in neuroendocrine tumorsL Bodei, D Ferone, C M Grana, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 10, 2011
Recent issues on dosimetry and radiobiology for peptide receptor radionuclide therapyM Cremonesi, M Ferrari, A Di Dia, et al.
British Journal of Cancer|March 6, 2003
Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma GroupT De Pas, L Bodei, G Pelosi, et al.
Pageof 4